Rene Lenggenhager

Rene Lenggenhager

Director/Board Member at NANALYSIS SCIENTIFIC CORP.

Net worth: 45 600 $ as of 2024-03-30

64 year
Health Technology
Consumer Services
Technology Services

Profile

Rene Lenggenhager is currently the CEO-Sales & Marketing & Director at bNovate Technologies SA and the Director at Nanalysis Scientific Corp.
He was previously the Chief Executive Officer at COMET Holding AG from 2017 to 2019, the President at Bruker Biospin Group from 2015 to 2017, and a Senior Manager at Mettler-Toledo GmbH (Switzerland) from 2000 to 2015.
Lenggenhager holds an MBA from the University of St. Gallen and a doctorate from the Swiss Federal Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-01 150,000 ( 0.15% ) 45 600 $ 2024-03-30

Rene Lenggenhager active positions

CompaniesPositionStart
NANALYSIS SCIENTIFIC CORP. Director/Board Member 2021-12-31
Director/Board Member -
All active positions of Rene Lenggenhager

Former positions of Rene Lenggenhager

CompaniesPositionEnd
COMET HOLDING AG Chief Executive Officer 2019-06-21
President 2017-02-23
Corporate Officer/Principal 2014-12-31
See the detail of Rene Lenggenhager's experience

Training of Rene Lenggenhager

University of St. Gallen Masters Business Admin
Swiss Federal Institute of Technology Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rene Lenggenhager's experience

Connections

31

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
COMET HOLDING AG

Health Technology

NANALYSIS SCIENTIFIC CORP.

Health Technology

Private companies3

Health Technology

Health Technology

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Rene Lenggenhager